RCEL
AVITA Medical, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$15.65
−6.34%Year over year
Reported trailing growth
- Revenue
- +1.0%
- EBITDA
- +21.2%
- EBIT
- +24.6%
- EPS
- +26.4%
- Free cash flow
- +43.9%
- Operating cash flow
- +32.4%
Forward estimates
Based on analyst estimates
- Revenue
- +39.1%
- EBITDA
- +65.3%
- EPS
- +54.1%
Three-year CAGR
- Revenue
- +27.7%
- EBITDA
- +25.5%
- EBIT
- +24.8%
- Net income
- +21.4%
- EPS
- +27.2%
- Free cash flow
- +43.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026